[1] Sayer AA, Cooper R, Arai H, et al.Sarcopenia[J]. Nat Rev Dis Primers, 2024, 10(1): 68. [2] Hu Y, Peng W, Ren R, et al.Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS[J]. J Cachexia Sarcopenia Muscle, 2022, 13(6): 2944-2952. [3] 江涛, 王新航, 张露艺, 等. 中国老年人肌少症患病率的Meta分析[J]. 海南医学, 2022, 33(1): 116-123. [4] LaMonte MJ, LaCroix AZ, Nguyen S, et al. Accelerometer-measured physical activity, sedentary time, and heart failure risk in women aged 63 to 99 years[J]. JAMA Cardiol, 2024, 9(4): 336-345. [5] Franssen WMA, Nieste I, Verboven K, et al.Sedentary behaviour and cardiometabolic health: Integrating the potential underlying molecular health aspects[J]. Metabolism, 2025, 70(1): 156320. [6] 余嘉铭, 张艳, 黄一沁, 等. 上海市社区老年人躯体衰弱与肌少症的相关性研究[J]. 老年医学与保健, 2020, 26(04): 519-523. [7] 马玲玲, 刘洪伯, 徐锐, 等. 住院老年患者肌少症患病情况及其影响因素分析[J]. 中国临床保健杂志, 2024, 27(3): 342-346. [8] Krishnamoorthy Y, Vijayageetha M, Saya GK.Validation and reliability assessment of the Mini-Nutritional Assessment-Short Form questionnaire among older adults in South India[J]. Indian J Community Med, 2021, 46(1): 70-74. [9] Tran VD, Do VV, Pham NM, et al.Validity of the International Physical Activity Questionnaire-Short Form for application in Asian countries: A study in Vietnam[J]. Eval Health Prof, 2020, 43(2): 105-109. [10] Chen LK, Woo J, Assantachai P, et al.Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. [11] 邹函怡, 王艺桦, 高明, 等. 社区老年人肌少症患病现状及影响因素分析[J]. 实用老年医学, 2023, 37(3): 246-250. [12] 纪雪莹, 保志军, 黄一沁, 等. 上海市社区老年人肌少症患病情况及相关因素分析[J]. 老年医学与保健, 2025, 31(6): 1474-1478, 1483. [13] 马浩宇, 乔鸿超, 郝茜茜, 等. 体育锻炼、久坐行为与肌少症风险——孟德尔随机化分析[J]. 现代预防医学, 2024, 51(15): 2824-2832, 2848. [14] Liu Y, Tang Z, Hou X, et al.Association of daily sitting time and leisure-time physical activity with sarcopenia among Chinese older adults[J]. Healthcare (Basel), 2025, 13(3): 251. [15] Deane CS, Piasecki M, Atherton PJ.Skeletal muscle immobilisation-induced atrophy: Mechanistic insights from human studies[J]. Clin Sci (Lond), 2024, 138(12): 741-756. [16] Donini LM, Busetto L, Bischoff SC, et al.Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement[J]. Obes Facts, 2022, 15(3): 321-335. [17] 孔健达, 解瑛傲, 陈世娟, 等. 血流限制训练干预老年肌少症:生物学机制和应用方案建议[J]. 中国组织工程研究, 2024, 28(23): 3743-3750. [18] Dreher SI, Grubba P, von Toerne C, et al. IGF1 promotes human myotube differentiation toward a mature metabolic and contractile phenotype[J]. Am J Physiol Cell Physiol, 2024, 326(5): 1462-1481. [19] Chien SY, Wang TH, Tzeng YL, et al.Time allocation to physical activity and sedentary behaviour and its impact on sarcopenia risk: A systematic review and meta-analysis[J]. J Adv Nurs, 2025, 81(10): 6250-6260. [20] Vanitcharoenkul E, Unnanuntana A, Chotiyarnwong P, et al.Sarcopenia in Thai community-dwelling older adults: A national, cross-sectional, epidemiological study of prevalence and risk factors[J]. BMC Public Health, 2024, 24(1): 311. [21] Yoh K, Ikeda K, Horie K, et al.Roles of estrogen, estrogen receptors, and estrogen-related receptors in skeletal muscle: Regulation of mitochondrial function[J]. Int J Mol Sci, 2023, 24(3): 1853. |